Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
Medtronic Analyst Ratings
Truist Financial Maintains Medtronic(MDT.US) With Hold Rating, Announces Target Price $90
Daiwa Securities Adjusts Price Target on Medtronic to $99 From $92, Maintains Buy Rating
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Raises Target Price to $105
A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $90 to $106
Medtronic Hold Rating Justified by Balanced Growth and Conservative Outlook
Medtronic Price Target Raised to $90.00/Share From $85.00 by Piper Sandler
Argus Research Releases a Buy Rating on Medtronic (MDT)
A Quick Look at Today's Ratings for Medtronic(MDT.US), With a Forecast Between $87 to $106
Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX) and Medtronic (MDT)
Wells Fargo Adjusts Price Target on Medtronic to $106 From $105, Maintains Overweight
Analysts Conflicted on These Healthcare Names: Medtronic (MDT) and Schrodinger (SDGR)
Medtronic Financial Analysis: A Balanced Hold Rating Amid Growth and Uncertainty
Medtronic Analyst Ratings
Medtronic's Strong Q1 Performance and Growth Prospects Merit a Buy Rating
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $104
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $104
Medtronic (MDT) Gets a Buy From Barclays
TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $95